These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861 [TBL] [Abstract][Full Text] [Related]
23. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S mBio; 2016 Dec; 7(6):. PubMed ID: 27965448 [TBL] [Abstract][Full Text] [Related]
24. Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak. Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D J Glob Antimicrob Resist; 2021 Mar; 24():90-92. PubMed ID: 33242672 [TBL] [Abstract][Full Text] [Related]
26. [The research progress in the etiological factor and the assay of SARS]. Wang ZF; Li JM Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):720-1. PubMed ID: 12914004 [No Abstract] [Full Text] [Related]
27. Possible central nervous system infection by SARS coronavirus. Lau KK; Yu WC; Chu CM; Lau ST; Sheng B; Yuen KY Emerg Infect Dis; 2004 Feb; 10(2):342-4. PubMed ID: 15030709 [TBL] [Abstract][Full Text] [Related]
28. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Chan KH; Cheng VC; Woo PC; Lau SK; Poon LL; Guan Y; Seto WH; Yuen KY; Peiris JS Clin Diagn Lab Immunol; 2005 Nov; 12(11):1317-21. PubMed ID: 16275947 [TBL] [Abstract][Full Text] [Related]
29. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro. Wang X; Xu W; Tong D; Ni J; Gao H; Wang Y; Chu Y; Li P; Yang X; Xiong S Immunol Lett; 2008 Aug; 119(1-2):71-7. PubMed ID: 18533276 [TBL] [Abstract][Full Text] [Related]
30. Animal studies hint at staying power of SARS. Pearson H Nature; 2003 May; 423(6938):370-1. PubMed ID: 12761509 [No Abstract] [Full Text] [Related]
31. [Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome]. Shi YL; Li LH; Sun ZH; Chen JY; Liao Y; Zeng LL; Zhang W; Chen XD; Cao C Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):795-9. PubMed ID: 21162846 [TBL] [Abstract][Full Text] [Related]
32. [A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS]. Yan HP; Tan YF; Zhuang H; Zhou YS; Zhao CH; Feng X; Jin RH; Wu H; Fu Y Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):896-9. PubMed ID: 17313874 [TBL] [Abstract][Full Text] [Related]
33. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice. Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307 [TBL] [Abstract][Full Text] [Related]
34. Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. He Z; Dong Q; Zhuang H; Song S; Peng G; Luo G; Dwyer DE Clin Diagn Lab Immunol; 2004 Jul; 11(4):792-4. PubMed ID: 15242960 [TBL] [Abstract][Full Text] [Related]
35. Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. Yoshikawa N; Yoshikawa T; Hill T; Huang C; Watts DM; Makino S; Milligan G; Chan T; Peters CJ; Tseng CT J Virol; 2009 Jun; 83(11):5451-65. PubMed ID: 19297479 [TBL] [Abstract][Full Text] [Related]
36. Profile of specific antibodies to the SARS-associated coronavirus. Li G; Chen X; Xu A N Engl J Med; 2003 Jul; 349(5):508-9. PubMed ID: 12890855 [No Abstract] [Full Text] [Related]
37. Lymphopenia and neutrophilia in SARS are related to the prevailing serum cortisol. Panesar NS; Lam CW; Chan MH; Wong CK; Sung JJ Eur J Clin Invest; 2004 May; 34(5):382-4. PubMed ID: 15147338 [No Abstract] [Full Text] [Related]
38. Epidemiology of SARS: the missing pathogen? Frizzell RA J Epidemiol Community Health; 2004 Sep; 58(9):801-2. PubMed ID: 15310809 [No Abstract] [Full Text] [Related]
39. [Predictors associated with clinical deterioration in SARS patients]. Yan J; Feng X; Tian JH; Xie Y; Yao J; He ZP; Xu DZ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):222-4. PubMed ID: 15340562 [TBL] [Abstract][Full Text] [Related]
40. Identification of human cell line model of persistent SARS coronavirus infection and studies of the response to cytokines and chemokines. To KF; Chan PK Hong Kong Med J; 2009 Oct; 15 Suppl 6():39-43. PubMed ID: 19801717 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]